Market Cap: $6.95M
XL
XTL Biopharmaceuticals Ltd.
XTLB
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $6.95M
Open
$2.59
Prev. Close
$2.90
High
$3.00
Low
$2.59
Strategic Acquisition Enhances Biopharmaceutical Capabilities for Servier In a significant development within the biopharmaceutical industry, Day One Biopharmaceuticals announces its acquisition by Se…
Rakuten Medical Enhances Manufacturing Capabilities through Strategic Partnership with LOTTE Biologics In a significant development at the J.P. Morgan Healthcare Conference, Rakuten Medical, Inc. anno…
X.T.L. Biopharmaceuticals Advances in mRNA Therapeutics Development X.T.L. Biopharmaceuticals, a frontrunner in the mRNA therapeutics space, announces significant progress in its proprietary drug deve…
Innovative Approaches to Obesity Management: Insights from Caliway Biopharmaceuticals' Research Caliway Biopharmaceuticals recently unveils its promising preclinical research on CBL-514 at the 25th An…